Meros Investment Management LP Raises Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Meros Investment Management LP lifted its holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 20.7% during the second quarter, Holdings Channel reports. The institutional investor owned 804,380 shares of the company’s stock after purchasing an additional 137,918 shares during the quarter. Meros Investment Management LP’s holdings in KORU Medical Systems were worth $2,132,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of KRMD. First Light Asset Management LLC lifted its holdings in KORU Medical Systems by 1.1% in the first quarter. First Light Asset Management LLC now owns 5,220,990 shares of the company’s stock valued at $12,322,000 after acquiring an additional 57,253 shares during the period. Archon Capital Management LLC increased its holdings in shares of KORU Medical Systems by 6.2% in the 1st quarter. Archon Capital Management LLC now owns 3,951,393 shares of the company’s stock valued at $9,325,000 after purchasing an additional 230,517 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of KORU Medical Systems by 2.7% in the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock valued at $4,630,000 after purchasing an additional 51,890 shares during the period. Lakewood Asset Management LLC boosted its holdings in KORU Medical Systems by 13.9% during the second quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock worth $181,000 after buying an additional 8,300 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in KORU Medical Systems during the second quarter worth about $107,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

Analyst Ratings Changes

KRMD has been the topic of a number of research reports. Piper Sandler upped their price target on KORU Medical Systems from $2.50 to $3.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. B. Riley assumed coverage on KORU Medical Systems in a research report on Thursday, July 25th. They set a “buy” rating and a $4.00 target price on the stock.

KORU Medical Systems Stock Performance

Shares of KRMD opened at $2.70 on Friday. KORU Medical Systems, Inc. has a 12-month low of $1.98 and a 12-month high of $3.09. The stock has a market cap of $123.80 million, a P/E ratio of -9.64 and a beta of 0.42. The company has a current ratio of 3.77, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average of $2.44 and a two-hundred day moving average of $2.35.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Wednesday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $8.43 million for the quarter, compared to analyst estimates of $7.52 million. KORU Medical Systems had a negative return on equity of 20.82% and a negative net margin of 38.16%. During the same quarter in the prior year, the company earned ($0.05) EPS. As a group, research analysts predict that KORU Medical Systems, Inc. will post -0.13 EPS for the current fiscal year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.